Budd–Chiari Syndrome: A case report

National Institute for Clinical Excellence (NICE). Heavy menstrual bleeding March 2018, www.nice.org.uk/guidance/cg88 (accessed 7 December 2018).

ACOG Committee Opinion No. 556. Postmenopausal oestrogen therapy: route of administration and risk of venous thromboembolism. Obstet Gynaecol 2013; 121: 887–890.

Smith NL Blondon M Wiggins KL et al . Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA 2014; 174: 25–31.

Canonico M Oger E Plu-bureau G et al. ; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among post menopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115: 840–845.

Idle SA Panay N Hamoda H. A national survey assessing the clinical practice of members of the British Menopause Society on the management of patients with unscheduled bleeding on hormone replacement therapy. Post Reproductive Health 2018; 24: 128.

Eisenberger A Westhoff C. Hormone replacement therapy and venous thromboembolism. J Steroid Biochem Mol Biol 2014; 142: 76–82.